Skip to main content

Driving and Inhibiting Factors of Single Cell Sequencing Market

 


A paradigm shift in the dynamics of the market is expected to be witnessed around 2029 with the introduction of imaging solutions and single cell automated system in full scale. The leading players in the market are undertaking the necessary steps to tackle the shift in dynamics and sustain the competition.

The global single cell sequencing market is divided into two main categories, instruments and consumables. Kits and consumables market share was valued at $727.2 million of the global single cell sequencing market value in 2018. Also, the kits and consumables is expected to witness impressive growth. The sub-segment is expected to grow with a CAGR of 15.67% during the forecast period 2019-2029. This reflects the dependency of single cell sequencing market on consumables, which is expected to continue to grow in the future.

Single cell sequencing workflow is majorly divided into three segments: single cell isolation, single cell preparation, and single cell analysis. Presently, the market is dominated by single cell analysis techniques. Several key players, such as 10x Genomics, Mission Bio, Bio-Rad Laboratories, and Fluidigm Corporation, have systems and platforms for single cell analysis.

The recent advancement in the technologies for single cell analysis and the availability of funding to promote the research on various applications of single cell technology are factors that have enabled the academic and research institutions to invest in various research studies on single cell sequencing.

Labels:

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

High-End Synthetic Suede Market Latest Trend, Industry Growth, Competitive Analysis Upto 2031

High-end synthetic suede has been able to mark its presence in the fashion industry as well. Global fashion designers, with an aim to inculcate sustainability, have started to incorporate synthetic materials in their production process, to not only achieve sustainability but also to send a strong message to their customers regarding the proliferated use of vegan materials. The growth in the high-end synthetic suede market is attributable to increasing demand from the automotive industry and the need for a replacement of natural suede. Synthetic suede is made through the blends of polyester and other plastics, posing less environmental hazard just like natural suede does. Synthetic suede is typically more economical and affordable as compared to natural suede. The material is highly durable and requires low maintenance, which has made it a popular choice as a replacement of natural suede. The increase in the number of end-use industries, rise in the demand for a replacement of natural s...
Post a Comment
Read more

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more